CAPMATINIB (INC280) IN MET Delta EX14-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) : EFFICACY DATA FROM THE PHASE 2 GEOMETRY MONO-1 STUDY
2019
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI